Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma

Fig. 3

Multiplex RT-qPCR immunotherapy panel and survival outcome of anti-PD-1 treated melanoma patients. Kaplan–Meier analysis of a progression-free survival and b overall survival of anti-PD-1 treated melanoma patients according to CD274, PDCD1LG2, CD8A, and IRF1 transcript expression by multiplex RT-qPCR immunotherapy panel. Low and high statuses were defined using median cut point

Back to article page